Petr Kujal
About
Petr Kujal is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Biochemistry.
According to data from OpenAlex, Petr Kujal has authored 34 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 20 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Biochemistry. Recurrent topics in Petr Kujal's work include Hormonal Regulation and Hypertension (17 papers), Renin-Angiotensin System Studies (15 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Petr Kujal is often cited by papers focused on Hormonal Regulation and Hypertension (17 papers), Renin-Angiotensin System Studies (15 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Petr Kujal collaborates with scholars based in Czechia, Poland and Germany. Petr Kujal's co-authors include Luděk Červenka, Zuzana Husková, Zdeňka Vernerová, Herbert J. Kramer, Janusz Sadowski, Věra Čertíková Chábová, Ivana Vaněčková, Elżbieta Kompanowska‐Jezierska, Libor Kopkan and John D. Imig and has published in prestigious journals such as Life Sciences, American Journal of Physiology-Renal Physiology and British Journal of Dermatology.
In The Last Decade
Petr Kujal
31 papers receiving 511 citations
Peers
Petr Kujal
L. Spadaro Italy
Raj Pandian United States
Rie Matsumori Japan
Rein Teesalu Estonia
Mohsen Kerkeni Tunisia
Marileda Novello Italy
I. Kardasz Italy
Nicholas Alp United Kingdom
D. Vallance United Kingdom
Gerald Klose Germany
Citations per year, relative to Petr Kujal Petr Kujal (= 1×)
peers
L. Spadaro
Countries citing papers authored by Petr Kujal
Since
Specialization
Citations
This map shows the geographic impact of Petr Kujal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Kujal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Kujal more than expected).
Fields of papers citing papers by Petr Kujal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Petr Kujal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Kujal. The network helps show where Petr Kujal may publish in the future.
Co-authorship network of co-authors of Petr Kujal
This figure shows the co-authorship network connecting the top 25 collaborators of Petr Kujal. A scholar is included among the top collaborators of Petr Kujal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Kujal. Petr Kujal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kujal, Petr, et al.. (2024). Sex-Linked Differences in Cardiac Atrophy After Mechanical Unloading Induced by Heterotopic Heart Transplantation. Physiological Research. 73(1/2024). 9–25.
2.
Hojná, Silvie, Hana Malínská, Martina Hüttl, et al.. (2024). Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet. Biomedicine & Pharmacotherapy. 174. 116520–116520.
3.
Kujal, Petr, et al.. (2024). Distribution of mechanical properties of native human ligamentum flavum depending on histopathological changes. Biomedical Physics & Engineering Express. 10(6). 65025–65025.
4.
Husková, Zuzana, Janusz Sadowski, Elżbieta Kompanowska‐Jezierska, et al.. (2024). Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome: insight from studies with Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula. Hypertension Research. 47(4). 998–1016.
5.
Sadowski, Janusz, et al.. (2023). Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?. Hypertension Research. 46(10). 2340–2355.
6.
Hüttl, Martina, Irena Marková, Petr Kujal, et al.. (2023). Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model. Frontiers in Pharmacology. 14. 1117683–1117683.
7.
Hojná, Silvie, Zdeňka Vaňourková, Hana Rauchová, et al.. (2022). Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease. Biomedicines. 10(10). 2509–2509.
8.
Hojná, Silvie, Hana Rauchová, Hana Malínská, et al.. (2021). Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension. Biomedicine & Pharmacotherapy. 144. 112246–112246.
9.
Šepitka, Josef, Matěj Daniel, Petr Kujal, et al.. (2020). The role of vascularization on changes in ligamentum flavum mechanical properties and development of hypertrophy in patients with lumbar spinal stenosis. The Spine Journal. 20(7). 1125–1133.
10.
Kujal, Petr, et al.. (2018). Cerebrovascular myocardium-tissue embolism: a rare complication of heart surgery: autopsy case report. Cardiovascular Pathology. 34. 46–49.
11.
Chábová, Věra Čertíková, Petr Kujal, Petra Škaroupková, et al.. (2018). Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Kidney & Blood Pressure Research. 43(2). 329–349.
12.
Kopkan, Libor, Zuzana Husková, Jan Neckář, et al.. (2016). Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established. Journal of Hypertension. 34(10). 2008–2025.
13.
Hampl, Václav, Jan Herget, Jana Bı́bová, et al.. (2015). Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2/Angiotensin 1-7/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia. Physiological Research. 64(1). 25–38.
14.
Husková, Zuzana, Libor Kopkan, Jan Neckář, et al.. (2015). Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats. Vascular Pharmacology. 73. 45–56.
15.
Chábová, Věra Čertíková, Zdeňka Vernerová, Petr Kujal, et al.. (2013). Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats. Life Sciences. 118(2). 297–305.
16.
Kitada, Kento, Zuzana Husková, Libor Kopkan, et al.. (2012). Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME. Journal of Hypertension. 31(2). 321–332.
17.
Kopkan, Libor, Zuzana Husková, Sung Hee Hwang, et al.. (2012). Soluble Epoxide Hydrolase Inhibition Exhibits Antihypertensive Actions Independently of Nitric Oxide in Mice with Renovascular Hypertension. Kidney & Blood Pressure Research. 35(6). 595–607.
18.
Kopkan, Libor, Zuzana Husková, Sung Hee Hwang, et al.. (2011). Inhibition of soluble epoxide hydrolase improves the impaired pressure–natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats. Journal of Hypertension. 29(8). 1590–1601.
19.
Kujal, Petr, Věra Čertíková Chábová, Zdeňka Vernerová, et al.. (2010). Similar renoprotection after renin‐angiotensin‐dependent and ‐independent antihypertensive therapy in 5/6‐nephrectomized Ren‐2 transgenic rats: are there blood pressure‐independent effects?. Clinical and Experimental Pharmacology and Physiology. 37(12). 1159–1169.
20.
Vernerová, Zdeňka, et al.. (2009). End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade. Physiological Research. 58 Suppl 2. S69–S78.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by L. Spadaro Breakdown of academic impact, for papers by Raj Pandian Breakdown of academic impact, for papers by Rie Matsumori Breakdown of academic impact, for papers by Rein Teesalu Breakdown of academic impact, for papers by Mohsen Kerkeni Breakdown of academic impact, for papers by Marileda Novello Breakdown of academic impact, for papers by I. Kardasz Breakdown of academic impact, for papers by Nicholas Alp Breakdown of academic impact, for papers by D. Vallance Breakdown of academic impact, for papers by Gerald Klose